• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
in the Faecal Microbiota Demonstrates a Direct Association with Arterial Hypertension in Individuals of the Kazakh Population Without Insulin Resistance.在哈萨克族人群中,粪便微生物群与无胰岛素抵抗个体的动脉高血压呈直接关联。
Int J Environ Res Public Health. 2024 Nov 22;21(12):1546. doi: 10.3390/ijerph21121546.
2
and in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study.慢性肝脏疾病和肝细胞癌患者的肠道微生物群减少:一项初步研究。
Bioengineered. 2021 Dec;12(1):8233-8246. doi: 10.1080/21655979.2021.1982273.
3
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.克罗恩病粪便宏基因组的调控:miRNAs 作为生物标志物的作用。
World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223.
4
Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals.正常体重的年轻个体反复部分睡眠剥夺对肠道微生物群和糖代谢的影响。
Mol Metab. 2016 Oct 24;5(12):1175-1186. doi: 10.1016/j.molmet.2016.10.003. eCollection 2016 Dec.
5
Gut Microbiota of Chinese Obese Children and Adolescents With and Without Insulin Resistance.中国肥胖儿童和青少年伴或不伴胰岛素抵抗的肠道微生物群。
Front Endocrinol (Lausanne). 2021 Mar 19;12:636272. doi: 10.3389/fendo.2021.636272. eCollection 2021.
6
Mild intermittent hypoxia exposure alters gut microbiota composition in men with overweight and obesity.轻度间歇性低氧暴露会改变超重和肥胖男性的肠道微生物群组成。
Benef Microbes. 2022 Oct 4;13(4):355-364. doi: 10.3920/BM2021.0159. Epub 2022 Jul 22.
7
Characterizing the fecal microbiota of infants with botulism.分析肉毒梭菌中毒婴儿的粪便微生物群。
Microbiome. 2015 Nov 23;3:54. doi: 10.1186/s40168-015-0119-0.
8
Faecal microbiota of healthy adults in south India: Comparison of a tribal & a rural population.印度南部健康成年人的粪便微生物群:部落人口与农村人口的比较。
Indian J Med Res. 2017 Feb;145(2):237-246. doi: 10.4103/ijmr.IJMR_639_14.
9
Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients.银屑病患者肠道微生物组特征分析及预测的代谢失调。
Exp Dermatol. 2018 Dec;27(12):1336-1343. doi: 10.1111/exd.13786. Epub 2018 Oct 22.
10
Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies.代谢健康标志物和肠道微生物多样性:两项基于人群的队列研究结果。
Diabetologia. 2021 Aug;64(8):1749-1759. doi: 10.1007/s00125-021-05464-w. Epub 2021 Jun 10.

引用本文的文献

1
..无内容,请提供需翻译的原文。
J Diabetes Metab Disord. 2025 May 29;24(1):129. doi: 10.1007/s40200-025-01643-3. eCollection 2025 Jun.

本文引用的文献

1
Host control of the microbiome: Mechanisms, evolution, and disease.宿主对微生物组的控制:机制、进化与疾病。
Science. 2024 Jul 19;385(6706):eadi3338. doi: 10.1126/science.adi3338.
2
Untapped potential of gut microbiome for hypertension management.肠道微生物组在高血压管理中的未开发潜力。
Gut Microbes. 2024 Jan-Dec;16(1):2356278. doi: 10.1080/19490976.2024.2356278. Epub 2024 Jun 2.
3
Research Progress on the Correlation Between Hypertension and Gut Microbiota.高血压与肠道微生物群相关性的研究进展
J Multidiscip Healthc. 2024 May 16;17:2371-2387. doi: 10.2147/JMDH.S463880. eCollection 2024.
4
Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity.肠道微生物群调节炎症和胰岛素抵抗:改善胰岛素敏感性的新治疗靶点。
Signal Transduct Target Ther. 2024 Feb 21;9(1):35. doi: 10.1038/s41392-024-01746-y.
5
Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.肠道微生物组及其在心血管疾病中的治疗干预作用。
Front Immunol. 2024 Jan 26;15:1321395. doi: 10.3389/fimmu.2024.1321395. eCollection 2024.
6
Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms.肥胖相关性高血压的机制与治疗——第1部分:机制
Clin Kidney J. 2023 Nov 13;17(1):sfad282. doi: 10.1093/ckj/sfad282. eCollection 2024 Jan.
7
Gut microbiota changes in patients with hypertension: A systematic review and meta-analysis.高血压患者肠道菌群变化的系统评价和荟萃分析。
J Clin Hypertens (Greenwich). 2023 Dec;25(12):1053-1068. doi: 10.1111/jch.14722. Epub 2023 Oct 18.
8
Predicting cardiovascular disease risk from gut microbial genes.从肠道微生物基因预测心血管疾病风险。
mBio. 2023 Dec 19;14(6):e0197023. doi: 10.1128/mbio.01970-23. Epub 2023 Oct 16.
9
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
10
Impact of gut microbiome on the renin-aldosterone system: Shika-machi Super Preventive Health Examination results.肠道微生物组对肾素-血管紧张素系统的影响:鹿儿岛町超级预防健康检查结果。
Hypertens Res. 2023 Oct;46(10):2280-2292. doi: 10.1038/s41440-023-01334-7. Epub 2023 Jun 6.

在哈萨克族人群中,粪便微生物群与无胰岛素抵抗个体的动脉高血压呈直接关联。

in the Faecal Microbiota Demonstrates a Direct Association with Arterial Hypertension in Individuals of the Kazakh Population Without Insulin Resistance.

作者信息

Abildinova Gulshara, Vochshenkova Tamara, Aitkaliyev Alisher, Abildinova Aizhan, Benberin Valeriy, Borovikova Anna, Bekenova Nazira, Kassiyeva Balzhan

机构信息

Department of Science, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Mangilik El 80, Astana 010000, Kazakhstan.

Municipal Polyclinic N° 9, Astana 010000, Kazakhstan.

出版信息

Int J Environ Res Public Health. 2024 Nov 22;21(12):1546. doi: 10.3390/ijerph21121546.

DOI:10.3390/ijerph21121546
PMID:39767388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11675478/
Abstract

The gut microbiota plays a fundamental role in the host's energy metabolism and the development of metabolic diseases such as arterial hypertension, insulin resistance, and atherosclerosis. Our study aimed to investigate the potential role of the gut microbiota in arterial hypertension among individuals of the Kazakh population without insulin resistance. 16S rRNA gene sequencing of faecal samples from 197 Kazakh subjects was performed. Preliminary binary comparisons of the faecal microbiota composition depending on the presence of arterial hypertension and insulin resistance revealed statistically significant differences in the abundance of the . Logistic regression analysis showed that only the influenced hypertension risk in individuals without insulin resistance after adjusting for age, sex, BMI, fasting glucose, triglycerides, and triglyceride-glucose index. The higher the abundance of the in faeces, the greater the risk of arterial hypertension (OR = 1.064 [95% CI 1.005-1.125]). Correlation analysis revealed a negative association between the abundance of the and the triglyceride-glucose index, primarily driven by triglyceride levels. These findings suggest the potential role of the gut microbiota, especially the , in the development of hypertension in individuals without insulin resistance.

摘要

肠道微生物群在宿主能量代谢以及动脉高血压、胰岛素抵抗和动脉粥样硬化等代谢性疾病的发展中起着重要作用。我们的研究旨在调查肠道微生物群在无胰岛素抵抗的哈萨克族人群动脉高血压中的潜在作用。对197名哈萨克族受试者的粪便样本进行了16S rRNA基因测序。根据动脉高血压和胰岛素抵抗的存在情况对粪便微生物群组成进行的初步二元比较显示,在……丰度上存在统计学显著差异。逻辑回归分析表明,在调整年龄、性别、体重指数、空腹血糖、甘油三酯和甘油三酯-葡萄糖指数后,只有……影响无胰岛素抵抗个体的高血压风险。粪便中……的丰度越高,动脉高血压风险越大(比值比=1.064[95%置信区间1.005-1.125])。相关性分析显示,……的丰度与甘油三酯-葡萄糖指数之间呈负相关,主要由甘油三酯水平驱动。这些发现表明肠道微生物群,尤其是……,在无胰岛素抵抗个体高血压发展中的潜在作用。